Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margreet Gem Ausems

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
BMC Cancer|January 17, 2014
The efficacy of a standardized questionnaire in facilitating personalized communication about problems encountered in cancer genetic counseling: design of a randomized controlled trialWillem Eijzenga, Neil K Aaronson, Irma Kluijt, et al.
The Journal of Pathology|August 21, 2018
Ethical considerations for modern molecular pathologyShoko Vos, Paul J van Diest, Margreet Gem Ausems, et al.
European Journal of Human Genetics : EJHG|April 14, 2016
Unsolicited findings of next-generation sequencing for tumor analysis within a Dutch consortium: clinical daily practice reconsideredRhodé M Bijlsma, Annelien L Bredenoord, Christa G Gadellaa-Hooijdonk, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|October 24, 2018
Identifying patients with a history of ovarian cancer for referral for genetic counselling: non-randomised comparison of two case-finding strategies in primary careCharles W Helsper, Liesbeth M Van Vliet, Mary E Velthuizen, et al.
Hereditary Cancer in Clinical Practice|August 14, 2010
A novel pathogenic MLH1 missense mutation, c.112A > C, p.Asn38His, in six families with Lynch syndromeEls van Riel, Margreet Gem Ausems, Frans Bl Hogervorst, et al.
Breast Cancer Research : BCR|December 1, 2010
Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriersLogan C Walker, Zachary S Fredericksen, Xianshu Wang, et al.
British Journal of Cancer|January 5, 2018
Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predispositionChristos Mikropoulos, Christina G Hutten Selkirk, Sibel Saya, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
BMC Cancer|January 17, 2014
The efficacy of a standardized questionnaire in facilitating personalized communication about problems encountered in cancer genetic counseling: design of a randomized controlled trialWillem Eijzenga, Neil K Aaronson, Irma Kluijt, et al.
The Journal of Pathology|August 21, 2018
Ethical considerations for modern molecular pathologyShoko Vos, Paul J van Diest, Margreet Gem Ausems, et al.
European Journal of Human Genetics : EJHG|April 14, 2016
Unsolicited findings of next-generation sequencing for tumor analysis within a Dutch consortium: clinical daily practice reconsideredRhodé M Bijlsma, Annelien L Bredenoord, Christa G Gadellaa-Hooijdonk, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|October 24, 2018
Identifying patients with a history of ovarian cancer for referral for genetic counselling: non-randomised comparison of two case-finding strategies in primary careCharles W Helsper, Liesbeth M Van Vliet, Mary E Velthuizen, et al.
Hereditary Cancer in Clinical Practice|August 14, 2010
A novel pathogenic MLH1 missense mutation, c.112A > C, p.Asn38His, in six families with Lynch syndromeEls van Riel, Margreet Gem Ausems, Frans Bl Hogervorst, et al.
Breast Cancer Research : BCR|December 1, 2010
Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriersLogan C Walker, Zachary S Fredericksen, Xianshu Wang, et al.
British Journal of Cancer|January 5, 2018
Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predispositionChristos Mikropoulos, Christina G Hutten Selkirk, Sibel Saya, et al.
Pageof 1